JP6830671B6
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
Abstract
This record has no abstract on file.
Term
10 yearsto projected expiry
Projected expiry 22 September 2036, counted from filing; an application has no term until it is granted.
- Priority and filed
- Published
- Today
- Projected expiry
38 members in 11 offices
Members38
| Document | Office | Kind | |
|---|---|---|---|
| CA2999367A1 | Canada | A1 | |
| CA3207643A1 | Canada | A1 | |
| WO2017049470A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2017050259A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201718456A | Taiwan Province of China | A | |
| AU2016328150A1 | Australia | A1 | |
| KR20180058738A | Republic of Korea | A | |
| CN108283000A | China | A | |
| EP3353145A1 | European Patent Office (EPO) | A1 | |
| JP2018532771A | Japan | A | |
| US2019194120A1 | United States of America | A1 | |
| US2019218168A1 | United States of America | A1 | |
| EP3353145A4 | European Patent Office (EPO) | A4 | |
| US10457627B2 | United States of America | B2 | |
| HK1257965A | Hong Kong, China | A | |
| HK1257965A1 | Hong Kong, China | A1 | |
| US10501401B2 | United States of America | B2 | |
| US2020039917A1 | United States of America | A1 | |
| US10640451B2 | United States of America | B2 | |
| US2020223783A1 | United States of America | A1 | |
| US10774031B2 | United States of America | B2 | |
| AU2016328150B2 | Australia | B2 | |
| US2020369598A1 | United States of America | A1 | |
| US2020369599A1 | United States of America | A1 | |
| TWI716458B | Taiwan Province of China | B | |
| JP6830671B2 | Japan | B2 | |
| US10941107B2 | United States of America | B2 | |
| JP6830671B6This record | Japan | B6 | |
| CN108283000B | China | B | |
| US2021130281A1 | United States of America | A1 | |
| JP2021073214A | Japan | A | |
| CN113061089A | China | A | |
| KR102279993B1 | Republic of Korea | B1 | |
| EP3353145B1 | European Patent Office (EPO) | B1 | |
| ES2930848T3 | Spain | T3 | |
| EP4119539A1 | European Patent Office (EPO) | A1 | |
| JP2023011677A | Japan | A | |
| CA2999367C | Canada | C |
16 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Receipt of annual feesJAPANESE INTERMEDIATE CODE: R250R250 | R250 | |
| Written measure of declining of transfer procedureJAPANESE INTERMEDIATE CODE: R370R370 | R370 | |
| Written notification for declining of transfer of rightsJAPANESE INTERMEDIATE CODE: R360R360 | R360 | |
| Written request for registration of reclamation of nameJAPANESE INTERMEDIATE CODE: R313633S633 | S633 | |
| Certificate of patent or registration of utility modelJAPANESE INTERMEDIATE CODE: R150R150 | R150 | |
| First payment of annual fees (during grant procedure)JAPANESE INTERMEDIATE CODE: A61A61 | A61 | |
| Written decision to grant a patent or to grant a registration (utility model)JAPANESE INTERMEDIATE CODE: A01A01 | A01 | |
| Decision of grant or rejection writtenTRDD | TRDD | |
| Request for written amendment filedJAPANESE INTERMEDIATE CODE: A523A521 | A521 | |
| Notification of reasons for refusalJAPANESE INTERMEDIATE CODE: A131A131 | A131 | |
| Report on retrievalJAPANESE INTERMEDIATE CODE: A971007A977 | A977 | |
| Request for written amendment filedJAPANESE INTERMEDIATE CODE: A523A521 | A521 | |
| Written request for application examinationJAPANESE INTERMEDIATE CODE: A621A621 | A621 | |
| Request for written amendment filedJAPANESE INTERMEDIATE CODE: A523A521 | A521 |
Numbers
- Publication
- 6830671
- Application
- 2018533996
Titles
- English
- Prodrug of γ-hydroxybutyric acid (GHB), its composition and use
Classification
- IPC, 6
- C07C229 08
- A61K31 223
- A61P25 00
- A61P25 16
- A61P25 18
- A61P25 28